Purpose
Cataract, a clouding of the intraocular lens, is the leading cause of blindness. The lens-expressed long noncoding RNA
OIP5-AS1
was upregulated in lens epithelial cells from patients with cataracts, suggesting its pathogenic role in cataracts. We investigated the regulatory role of
OIP5-AS1
in the development of cataracts as well as potential RNA binding proteins, downstream target genes, and upstream transcription factors.
Methods
Clinical capsules and ex vivo and in vitro cataract models were used to test
OIP5-AS1
expression. Cell apoptosis was detected using Western blots, JC-1 staining, and flow cytometry. Ribonucleoprotein immunoprecipitation-qPCR was performed to confirm the interaction of
OIP5-AS1
and
POLG
. Chromatin immunoprecipitation-qPCR was used to determine the binding of TFAP2A and the
OIP5-AS1
promoter region.
Results
OIP5-AS1
was upregulated in cataract lenses and B3 cells under oxidative stress.
OIP5-AS1
knockdown protected B3 cells from H
2
O
2
-induced apoptosis and alleviated lens opacity in the ex vivo cataract model. HuR functioned as a scaffold carrying
OIP5-AS1
and
POLG
mRNA and mediated the decay of
POLG
mRNA.
POLG
was downregulated in the cataract lens and oxidative-stressed B3 cells, and
POLG
depletion decreased the mtDNA copy number and MMP, increased reactive oxygen species production, and sensitized B3 cells to oxidative stress-induced apoptosis.
POLG
overexpression reversed these effects. TFAP2A bound the
OIP5-AS1
promoter and contributed to
OIP5-AS1
expression.
Conclusions
We demonstrated that
OIP5-AS1
, activated by TFAP2A
,
contributed to cataract formation by inhibiting
POLG
expression mediated by HuR, thus leading to increased apoptosis of lens epithelial cells and aggravated lens opacity, suggesting that
OIP5-AS1
is a potential target for cataract treatment.